Abstract
Anecdotal observation of mammographic changes in patients receiving hormonal replacement therapy prompted a retrospective review of a screening population of 1,500 consecutive patients. Thirty patients were identified who underwent mammography both before or after therapy and during therapy. The duration of hormonal replacement therapy ranged from 1 to 72 months (mean, 22.2 months). An increase in fibroglandular tissue was seen on the mammograms of five of the 30 patients (17%) receiving therapy. The mammograms from the remaining 25 patients (83%) showed no change. A proportion of women receiving hormonal replacement therapy will show increased tissue density at mammography. Awareness of this reponse should temper concern and, in the absence of suggestive anatomic changes, allow for serial, vigilant monitoring of these patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 199-201 |
| Number of pages | 3 |
| Journal | Radiology |
| Volume | 174 |
| Issue number | 1 |
| State | Published - Jan 1990 |
Fingerprint
Keywords
- Breast, parenchymal pattern, 00.59,00.92
- Drugs, effects, 00.59
- Hormones
ASJC Scopus subject areas
- Radiological and Ultrasound Technology
Cite this
Hormonal replacement therapy : Mammographic manifestations. / Berkowitz, Joan E.; Gatewood, Olga M B; Goldblum, Liba E.; Gayler, Bob W.
In: Radiology, Vol. 174, No. 1, 01.1990, p. 199-201.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hormonal replacement therapy
T2 - Mammographic manifestations
AU - Berkowitz, Joan E.
AU - Gatewood, Olga M B
AU - Goldblum, Liba E.
AU - Gayler, Bob W.
PY - 1990/1
Y1 - 1990/1
N2 - Anecdotal observation of mammographic changes in patients receiving hormonal replacement therapy prompted a retrospective review of a screening population of 1,500 consecutive patients. Thirty patients were identified who underwent mammography both before or after therapy and during therapy. The duration of hormonal replacement therapy ranged from 1 to 72 months (mean, 22.2 months). An increase in fibroglandular tissue was seen on the mammograms of five of the 30 patients (17%) receiving therapy. The mammograms from the remaining 25 patients (83%) showed no change. A proportion of women receiving hormonal replacement therapy will show increased tissue density at mammography. Awareness of this reponse should temper concern and, in the absence of suggestive anatomic changes, allow for serial, vigilant monitoring of these patients.
AB - Anecdotal observation of mammographic changes in patients receiving hormonal replacement therapy prompted a retrospective review of a screening population of 1,500 consecutive patients. Thirty patients were identified who underwent mammography both before or after therapy and during therapy. The duration of hormonal replacement therapy ranged from 1 to 72 months (mean, 22.2 months). An increase in fibroglandular tissue was seen on the mammograms of five of the 30 patients (17%) receiving therapy. The mammograms from the remaining 25 patients (83%) showed no change. A proportion of women receiving hormonal replacement therapy will show increased tissue density at mammography. Awareness of this reponse should temper concern and, in the absence of suggestive anatomic changes, allow for serial, vigilant monitoring of these patients.
KW - Breast, parenchymal pattern, 00.59,00.92
KW - Drugs, effects, 00.59
KW - Hormones
UR - http://www.scopus.com/inward/record.url?scp=0025099371&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025099371&partnerID=8YFLogxK
M3 - Article
C2 - 2152982
AN - SCOPUS:0025099371
VL - 174
SP - 199
EP - 201
JO - Radiology
JF - Radiology
SN - 0033-8419
IS - 1
ER -